Tarsier Pharma
Israel · Biopharma, Biotechnology, Health Care
Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and inflammatory ocular diseases. The company's most advanced candidate, TRS01 – an eye drop formulation of dazdotuftide, is entering its second phase 3 trial supported by a SPA agreement from the FDA.
Key facts
- Headquarters
- Israel
- Employees
- 10
- Industries
- Biopharma, Biotechnology, Health Care
- Website
- tarsierpharma.com
- Company page
Recent activity at Tarsier Pharma
Leadership
- Ashley Kline, Chief Commercial Officer
- Emilee Fulcher, Vice President
Verified email and direct lines for Tarsier Pharma’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Tarsier Pharma in the news
- Tarsier Pharma Receives FDA Agreement Under Special Protocol Assessment (SPA) for Tarsier-04 Phase 3 Trial of TRS01 Ophthalmic Solution for the Treatment of Non-infectious Uveitis including Uveitic Glaucoma - PR Newswire (Jan 16, 2024)
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer, Expanding Its U.S. Presence - PR Newswire (Jan 07, 2025)
Companies similar to Tarsier Pharma
- Ensho Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Verdiva Bio · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Lighthouse Pharmaceuticals · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Poolbeg Pharma plc · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- ANANDA Scientific · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Tarsier Pharma: questions and answers
What does Tarsier Pharma do?
Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and inflammatory ocular diseases. The company's most advanced candidate, TRS01 – an eye drop formulation of dazdotuftide, is entering its second phase 3 trial supported by a SPA agreement from the FDA.
Where is Tarsier Pharma headquartered?
Tarsier Pharma is headquartered in Israel.
How many employees does Tarsier Pharma have?
Tarsier Pharma has about 10 employees.
Who leads Tarsier Pharma?
Emilee Fulcher is a Vice President at Tarsier Pharma.
What is the latest news on Tarsier Pharma?
On Jan 07, 2025, Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy